Multi Medika Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Multi Medika Internasional Tbk. trades at Rp850 (market cap 4.01T, 54.76M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Multi Medika Internasional Tbk. is far larger — about 24.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Multi Medika Internasional Tbk. is more actively traded (54.76M versus 324K). Which is the better fit depends on your goals.
| MMIX | OBAT | |
|---|---|---|
Market Cap | 4.01T | 166.01B |
Volume | 54.76M | 324K |
Lot | 547.61K | 3.24K |
Turnover | 45.99B | 77.68M |
Average Price | 839.86 | 239.75 |
Value | 45.99B | 77.68M |
Indicative Equilibrium Price | 850 | 240 |
Indicative Equilibrium Volume | 3.37K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Medika Internasional Tbk (the Entity) was established based on the Notarial Deed of Ilmiawan Dekrit S., S.H., M.H., No. 23, dated September 28, 2020. The Entity commenced its commercial operations in 2020.
Read more on MMIX →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →